Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

ClinicalTrials.gov ID: NCT02079909

Public ClinicalTrials.gov record NCT02079909. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 4:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective is to evaluate the efficacy of T-817MA as measured by ADAS-cog and ADCS-CGIC. The secondary objectives are: * To evaluate the safety and tolerability of T-817MA measured by clinical safety laboratories, physical examinations, ECGs and solicitation of adverse events. * To evaluate the efficacy of T-817MA as measured by ADCS-ADL, FAQ, Neuropsychiatric Inventory (NPI) and Mini-mental State Examination (MMSE).

Study identification

NCT ID
NCT02079909
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
482 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2014
Primary completion
May 4, 2017
Completion
May 4, 2017
Last update posted
Feb 25, 2019

2014 – 2017

United States locations

U.S. sites
50
U.S. states
27
U.S. cities
49
Facility City State ZIP Site status
Banner Alzheimer's Institute Phoenix Arizona
Banner Sun Health Research Institute Sun City Arizona
University of Arizona Health Sciences Center Tucson Arizona
Neurology Center of North Orange County Fullerton California
UCSD Comprehensive Alzheimer's Program La Jolla California
UC Irvine Medical Center Orange California
Geriatric and Adult Psychiatry, LCC Hamden Connecticut
Yale University, Alzheimer's Disease Research Unit New Haven Connecticut
Research Center for Clinical Studies, Inc. Norwalk Connecticut
Georgetown University Clinical Research Unit Washington D.C. District of Columbia
Infinity Clinical Research, LLC Hollywood Florida
University of Miami Miller-School of Medicine Miami Florida
Scientific Clinical Research, Inc North Miami Florida
Renstar Medical Research Ocala Florida
Meridien Research Tampa Florida
Neuro Trials Research, Inc Atlanta Georgia
Rush University Medical Center Chicago Illinois
SIU School of Medicine Springfield Illinois
Indiana Medical Research Elkhart Indiana
Indiana University Health Partners, Adult Neurology Clinic Indianapolis Indiana
University of Iowa Hospitals and Clinics Iowa City Iowa
University of Kansas/Clinical and Translational Science Unit Fairway Kansas
University of Kentucky Sanders-Brown Center on Aging Clinic Lexington Kentucky
Pennington Biomedical Research Center Baton Rouge Louisiana
Acadia Hospital Bangor Maine
Boston University Alzheimer's Disease Center Boston Massachusetts
University of Michigan Health System/ Michigan Clinical Research Unit Ann Arbor Michigan
Michigan State University East Lansing Michigan
Bronson Neurobehvioral Health Paw Paw Michigan
University of Nebraska Medical Center(Geri Psych) Omaha Nebraska
Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada
Global Medical Institutes, LLC;Princeton Medical Institute Princeton New Jersey
Dent Neurologic Institute Amherst New York
Alzheimer's Disease Research Center of Mount Sinai New York New York
Columbia University Medical Center Sergievsky Center Taub Institute New York New York
The Nathan S. Kline Instituite for Psychiatric Research Orangeburg New York
University of Rochester Medical Center Rochester New York
SUNY Upstate Medical University Syracuse New York
Wake Forest University (WFU) School of Medicine Winston-Salem North Carolina
Case Western Reserve University/ University Hospitals Case Medical Center Beachwood Ohio
Tulsa Clinical Research, LLC Tulsa Oklahoma
Hospital at the University of Pennsylvania, Penn Memory Center Philadelphia Pennsylvania
University of Pittsburgh, Alzheimer Disease Research Center Pittsburgh Pennsylvania
Abington Neurological Associates, LTD. Willow Grove Pennsylvania
Roper St. Francis Healthcare Charleston South Carolina
Vanderbilt University Medical Center -VUIIS Nashville Tennessee
University of North Texas Health Science Center Fort Worth Texas
Houston Methodist Hospital Houston Texas
University of Wisconsin Hospital and Clinics Madison Wisconsin
Cary J. Kohlenberg MD., SC dba IPC Research Waukesha Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02079909, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2019 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02079909 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →